Table 1.

Effects of GLE on serum hepatic function in tumor-bearing mice.

Indexes	Control	Model	High dose	Medium dose	Low dose	Cisplatin
ALT(U/L)	30.00 ± 3.08	41.00 ± 8.69*	45.00 ± 2.74ΔΔ	34.40 ± 2.07ΔΔ	33.00 ± 3.74	50.40 ± 6.95**
AST(U/L)	119.00 ± 21.30	254.00 ± 39.12**	166.80 ± 11.82ΔΔ	149.00 ± 27.45ΔΔ	164.00 ± 10.15ΔΔ	262.80 ± 21.50**
TBIL(μmol/L)	2.20 ± 0.45	3.50 ± 0.50**	2.40 ± 0.55	1.80 ± 0.84	1.60 ± 0.55ΔΔ	2.40 ± 0.89

Note: ^*P < 0.05; ^**P < 0.01, versus control values; ^ΔP < 0.05; ^ΔΔP < 0.01, versus model values.